세계의 당뇨병성 신경병증 치료제 시장 (2023~2030) : 말초 신경병증, 자율 신경병증, 근위부 신경병증, 국소 신경병증

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Diabetic Neuropathy Treatment Market, by Region, 2020-2030 (USD Billion)
1.2.2. Diabetic Neuropathy Treatment Market, by Disorder Type, 2020-2030 (USD Billion)
1.2.3. Diabetic Neuropathy Treatment Market, by Drug Class, 2020-2030 (USD Billion)
1.2.4. Diabetic Neuropathy Treatment Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Diabetic Neuropathy Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Diabetic Neuropathy Treatment Market Dynamics
3.1. Diabetic Neuropathy Treatment Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of diabetes
3.1.1.2. Rising geriatric population
3.1.1.3. Increasing healthcare expenditure across worldwide
3.1.2. Market Challenges
3.1.2.1. Lack of awareness and education
3.1.2.2. Side effects of medications
3.1.3. Market Opportunities
3.1.3.1. Rising research and development activities to discover new drugs and therapies
3.1.3.2. Growing focus on patient-centric care
Chapter 4. Global Diabetic Neuropathy Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Diabetic Neuropathy Treatment Market, by Disorder Type
5.1. Market Snapshot
5.2. Global Diabetic Neuropathy Treatment Market by Disorder Type, Performance – Potential Analysis
5.3. Global Diabetic Neuropathy Treatment Market Estimates & Forecasts by Disorder Type 2020-2030 (USD Billion)
5.4. Diabetic Neuropathy Treatment Market, Sub Segment Analysis
5.4.1. Peripheral Neuropathy
5.4.2. Autonomic Neuropathy
5.4.3. Proximal Neuropathy
5.4.4. Focal Neuropathy
Chapter 6. Global Diabetic Neuropathy Treatment Market, by Drug Class
6.1. Market Snapshot
6.2. Global Diabetic Neuropathy Treatment Market by Drug Class, Performance – Potential Analysis
6.3. Global Diabetic Neuropathy Treatment Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
6.4. Diabetic Neuropathy Treatment Market, Sub Segment Analysis
6.4.1. Capsaicin
6.4.2. Opioid
6.4.3. Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
6.4.4. Antidepressants
6.4.5. Others
Chapter 7. Global Diabetic Neuropathy Treatment Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Diabetic Neuropathy Treatment Market by Distribution Channel, Performance – Potential Analysis
7.3. Global Diabetic Neuropathy Treatment Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4. Diabetic Neuropathy Treatment Market, Sub Segment Analysis
7.4.1. Hospitals Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Other
Chapter 8. Global Diabetic Neuropathy Treatment Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Diabetic Neuropathy Treatment Market, Regional Market Snapshot
8.4. North America Diabetic Neuropathy Treatment Market
8.4.1. U.S. Diabetic Neuropathy Treatment Market
8.4.1.1. Disorder Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Drug Class breakdown estimates & forecasts, 2020-2030
8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Diabetic Neuropathy Treatment Market
8.5. Europe Diabetic Neuropathy Treatment Market Snapshot
8.5.1. U.K. Diabetic Neuropathy Treatment Market
8.5.2. Germany Diabetic Neuropathy Treatment Market
8.5.3. France Diabetic Neuropathy Treatment Market
8.5.4. Spain Diabetic Neuropathy Treatment Market
8.5.5. Italy Diabetic Neuropathy Treatment Market
8.5.6. Rest of Europe Diabetic Neuropathy Treatment Market
8.6. Asia-Pacific Diabetic Neuropathy Treatment Market Snapshot
8.6.1. China Diabetic Neuropathy Treatment Market
8.6.2. India Diabetic Neuropathy Treatment Market
8.6.3. Japan Diabetic Neuropathy Treatment Market
8.6.4. Australia Diabetic Neuropathy Treatment Market
8.6.5. South Korea Diabetic Neuropathy Treatment Market
8.6.6. Rest of Asia Pacific Diabetic Neuropathy Treatment Market
8.7. Latin America Diabetic Neuropathy Treatment Market Snapshot
8.7.1. Brazil Diabetic Neuropathy Treatment Market
8.7.2. Mexico Diabetic Neuropathy Treatment Market
8.8. Middle East & Africa Diabetic Neuropathy Treatment Market
8.8.1. Saudi Arabia Diabetic Neuropathy Treatment Market
8.8.2. South Africa Diabetic Neuropathy Treatment Market
8.8.3. Rest of Middle East & Africa Diabetic Neuropathy Treatment Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Pfizer Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Eli Lilly and Company
9.3.3. Johnson & Johnson
9.3.4. Abbott Laboratories
9.3.5. Novo Nordisk A/S
9.3.6. Astellas Pharma Inc.
9.3.7. GlaxoSmithKline plc
9.3.8. Merck & Co., Inc.
9.3.9. Teva Pharmaceutical Industries Ltd.
9.3.10. Boehringer Ingelheim International GmbH
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption